References
- Bogdanic N, Balen Topic M. High recurrence and in-hospital mortality rates, and rising proportion of healthcare-associated Clostridium difficile infections in a university hospital in Croatia. Infect Dis. 2018;Sep 28:1–4, Epub ahead of print.
- Garey KW, Sethi S, Yadav Y, et al. Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. J Hosp Infect. 2008;70:298–304.
- Lee E, Song KH, Bae JY, et al. Risk factors for poor outcome in community-onset Clostridium difficile infection. Antimicrob Resist Infect Control. 2018;7:75.
- Pechal A, Lin K, Allen S, et al. National age group trends in Clostridium difficile infection incidence and health outcomes in United States Community Hospitals. BMC Infect Dis. 2016;16:682.
- Ofori E, Ramai D, Dhawan M, et al. Community-acquired Clostridium difficile: epidemiology, ribotype, risk factors, hospital and intensive care unit outcomes, and current and emerging therapies. J Hosp Infect. 2018;99:436–442.
- Berry CE, Davies KA, Owens DW, et al. Is there a relationship between the presence of the binary toxin genes in Clostridium difficile strains and the severity of C. difficile infection (CDI)? Eur J Clin Microbiol Infect Dis. 2017;36:2405–2415.
- Patel I, Wungjiranirun M, Theethira T, et al. Lack of adherence to SHEA-IDSA treatment guidelines for Clostridium difficile infection is associated with increased mortality. J Antimicrob Chemother. 2017;72:574–581.
- Reveles KR, Lawson KA, Mortensen EM, et al. National epidemiology of initial and recurrent Clostridium difficile infection in the Veterans Health Administration from 2003 to 2014. PLoS One. 2017;12:e0189227.